RxDoctor Payments Data

Bradford Croft, DO

Family Medicine · Flagstaff, AZNPI 1639241326

Payments from drug & device makers

$1,258in general payments, 2019–2025

Across 60 payments — averaging $20.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$335
  • Amgen$248
  • Johnson & Johnson$110
  • Abiomed$88
  • Abbott$74
  • Novo Nordisk$73
  • plus $330 from 11 others

What the payments were for

  • Food & beverage$1,24499%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,258 in reported general payments places this provider in the 70th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$160,321
Medicare patients
502
Services billed
1,785

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban14$13,748
XareltoRivaroxaban11$13,739
SynthroidLevothyroxine Sodium16$1,279
Atorvastatin Calcium159$1,085
Levothyroxine Sodium90$730
Olmesartan Medoxomil36$718
Testosterone14$700
Lisinopril123$572
Ezetimibe22$471
Meloxicam77$431
Allopurinol51$421
Metformin Hcl64$337
Venlafaxine Hcl ErVenlafaxine Hcl12$281
Rosuvastatin Calcium37$272
Simvastatin58$257

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$68$13,74814 claims
Johnson & JohnsonXarelto$110$13,73911 claims
AbbVieSynthroid$35$1,27916 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Flagstaff

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →